[4:18 a.m., 2022-01-17] Vikrant Sharma: Blundell Biotech. Blundell Biotech is a U.S.-based biotechnology company with operations and earnings in a number of foreign countries. The company's profits by subsidiary, in local currency (in millions), are shown in the table LOADING... for 2013 and 2014. a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014? b. If the same exchange rates were used for both years, what was the change in corporate earnings on a "constant currency" basis? c. Using the results of the constant currency analysis in part (b), is it possible to separate Blundell's growth in earnings between local currency earnings and foreign exchange rate impacts on a consolidated basis? Question content area [4:18 a.m., 2022-01-17] Vikrant Sharma: (a) Japanese Subsidiary British Subsidiary European Subsidiary Chinese Subsidiary Russian Subsidiary United States Subsidiary Net Income JPY GBP EUR CNY RUB USD 2013 1,494 97.43 200.39 165.67 122.13 352.91 2014 1,455 107.31 207.96 193.55 120.67 374.48 (b) Exchange Rate JPY = 1 USD USD = 1 GBP USD = 1 EUR CNY = 1 USD RUB = 1 USD USD 2013 97.57 1.5064 1.2339 6.0519 31.83 1 2014 105.95 1.6455 1.3561 6.1489 38.63 1 [4:19 a.m., 2022-01-17] Vikrant Sharma: a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014? Consolidated profits or earnings is found by consolidating the converted profits in each foreign currency to U.S. dollars for that period. (This is simplified. Actual accounting practices would require the additional netting of any intra-company transactions resulting to eliminate any double-counting of profits.) Calculate the consolidated profits in U.S. dollars in 2013 and 2014 below:(Round to two decimal places) Net Income Japanese (USD) Subsidiary (2013) (2014) Change (%